Ranbaxy Q3 is now In Profit
On thursday 11 November 2010, Ranbaxy Laboratories reported net profit to Rs. 313 crore for the third quarter Rnbaxy firm's sales increased 13% . during the quarter in comparison to the corresponding quarter in pervious year, Ranbaxy's net margin improved. Arun Sawhney who is MD of Ranbaxy said that their key markets continued to perform well attributable in large measure to balanced sales around $32 million to be estimate because benifit of foreign exchange benifit. During the quarter stood around $32 million operational profits. $106 million sales in Indial, 18% over growth in perivous quarter $145 million sales in developed markets total growth of 36%.
No responses found. Be the first to comment...